Compagnie Lombard Odier SCmA’s Guardant Health GH Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,000	Closed	-$35.8K	–	603
2023 Q2	$35.8K	Hold	1,000	–	–	﹤0.01%	442
2023 Q1	$23.4K	Hold	1,000	–	–	﹤0.01%	508
2022 Q4	$27K	Hold	1,000	–	–	﹤0.01%	551
2022 Q3	$54K	Hold	1,000	–	–	﹤0.01%	458
2022 Q2	$40K	Buy	+1,000	New	+$49.5K	﹤0.01%	468

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Compagnie Lombard Odier SCmA's GH Position: Q3 2023 in Review

Compagnie Lombard Odier SCmA sold out of Guardant Health (GH) in Q3 2023, closing a stake of 1,000 shares — an estimated $35.8K sold.

Compagnie Lombard Odier SCmA first reported a position in GH in Q2 2022 and held it in 5 quarters. The position peaked at $54K in Q3 2022. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

Compagnie Lombard Odier SCmA reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 1,000 Guardant Health shares in Q3 2023, an estimated $35.8K.
Compagnie Lombard Odier SCmA first reported a position in Guardant Health in Q2 2022 and held it in 5 quarters.
Compagnie Lombard Odier SCmA's Guardant Health position peaked at $54K in Q3 2022.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2023, filed 23 Oct 2023.